Search

everythinglearnresearchcommunity

for

Search:↓

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Finasteride may improve prostate cancer treatment outcomes.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

New progesterone-based compounds can block male hormones.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Tofacitinib treatment for hair loss may worsen acne.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.